On July 21, 2021, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and the Registrant wherein the Registrant agreed to conditions and/or limits on their nursing practice to ensure their fitness to practice. The concerns underpinning the Agreement relate to the Registrant diverting significant amounts of narcotics from the workplace for an extended period of time, practising while impaired and falsification of records in order to conceal the diversion activities. The undertakings include, but are not limited to: a two month suspension, regular reports from a medical monitoring agency regarding compliance with treatment recommendations, disclosure of treatment recommendations to relevant employer representative(s), and a limit on practice precluding access to narcotics, benzodiazepines, controlled substances, and atypical sedatives (also known as the “zed” class of drugs) for a term; a limit to which clinical setting the Registrant may work; not practising as the sole RN on shift; a restriction to working on one unit; a restriction from being in charge or being assigned supervision over students; and a restriction from working overtime. The Agreement will remain in place for a minimum of six years of continuous full-time nursing practice.
The reasons for the Inquiry Committee decision are as follows:
| a) | The Registrant provided an independent medical assessment documenting health concerns to BCCNM which could impact the ability to provide safe patient care. |
| b) | The independent medical assessment identified the Registrant is fit to practice nursing with conditions and/or limits, and they provided information regarding compliance with treatment recommendations.
|
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied the terms will protect the public.